Ruxandra Draghia-Akli
EVP, Research & Development · 2 filings · Latest: Mar 2, 2026
NOVAVAX INC
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
NVAX | Ruxandra Draghia Akli | — | May 27, 2026 | Proposed Sale | $11.01 | 21,383 | $235.4K | — | |
NVAX | Ruxandra Draghia Akli | — | May 7, 2026 | Proposed Sale | $9.87 | 30,000 | $296.1K | — | |
NVAX | Ruxandra Draghia-Akli | EVP, Research & Development | Mar 3, 2026 | Option Exercise | $0.00 | 26,667 | — | 34,876 |